Uncomplicated Staphylococcus aureus Bacteremia Treatment Duration and Outcomes at an Academic Medical Center

被引：3
|
作者：
Taupin, Daniel [1 ]
Karchmer, Adolf W. [1 ]
Davis, Roger B. [2 ]
LaSalvia, Mary T. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2020年 / 7卷 / 10期
基金：
美国国家卫生研究院;
关键词：
antibiotic duration; staphylococcal infections; uncomplicated bacteremia; MANAGEMENT; CARE;
D O I：
10.1093/ofid/ofaa457
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We compared outcomes and clinical characteristics of uncomplicated Staphylococcus aureus bacteremia planned for a 14-day or >14-day course of intravenous antibiotics. Treatment failure was infrequent in both groups (0% and 5%, respectively). Catheter-associated deep vein thrombosis, immunosuppression, and valvular dysfunction were associated with a longer planned duration of therapy.
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [21] A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia in a Tertiary Care VA Medical Center
    Carr, Dustin R.
    Stiefel, Usha
    Bonomo, Robert A.
    Burant, Christopher J.
    Sims, Sharanie V.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (05):
  • [22] Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia
    Lodise, TP
    McKinnon, PS
    Swiderski, L
    Rybak, MJ
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) : 1418 - 1423
  • [23] Shortening the Duration of Therapy for Staphylococcus aureus Bacteremia: Opening the Overton Window
    Tong, Steven Y. C.
    Walls, Genevieve
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : 873 - 875
  • [24] Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Choo, Eun Ju
    Chambers, Henry F.
    INFECTION AND CHEMOTHERAPY, 2016, 48 (04): : 267 - 273
  • [25] Persistent Staphylococcus aureus Bacteremia -: An analysis of risk factors and outcomes
    Hawkins, Claudia
    Huang, Jenny
    Jin, Nancy
    Noskin, Gary A.
    Zembower, Teresa R.
    Bolon, Maureen
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (17) : 1861 - 1867
  • [26] The impact of methicillin resistance on outcomes in patients with Staphylococcus aureus bacteremia
    Lodise, TP
    McKinnon, PS
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1229 - 1229
  • [27] Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia
    Rosa, Rossana
    Wawrzyniak, Andrew
    Sfeir, Maroun
    Smith, Laura
    Abbo, Lilian M.
    JOURNAL OF HOSPITAL MEDICINE, 2016, 11 (01) : 27 - 32
  • [28] COSTS AND OUTCOMES ASOCIATED WITH MULTIDRUG RESISTANT STAPHYLOCOCCUS AUREUS BACTEREMIA
    Singh, S.
    Tiwari, P.
    VALUE IN HEALTH, 2013, 16 (07) : A712 - A712
  • [29] The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
    Honda, Hitoshi
    Doern, Christopher D.
    Michael-Dunne, Wm, Jr.
    Warren, David K.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [30] OPTIMAL DURATION OF THERAPY FOR CATHETER-RELATED STAPHYLOCOCCUS-AUREUS BACTEREMIA
    WIDMER, AF
    PITTET, D
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (06) : 1259 - 1259
12345